Here are four other things to know from the quarter:
1. ASCs drove quarterly purchasing, culminating in a 111 percent increase over the third quarter of 2019, with repeat customers representing 98 percent of fourth-quarter order volume.
2. Despite strong revenue growth, EyePoint posted a $10.4 million loss on the quarter and a $56.8 million loss on the year.
3. During the quarter, EyePoint appointed George Elston CFO and issued a public offering of 15 million shares of common stock at a price of $1.45 per share.
4. EyePoint believes its combination of cash and cash equivalents, along with the proceeds from the public offering and incoming cash, will fund the company’s operations through 2021.
More articles on surgery centers:
Orthopedic spine & neurosurgery specialists join New York Rothman Orthopaedics ASC
North Carolina spine surgery center moves to renovated VA clinic
3 spine procedures that cost hundreds less at ASCs
